A Bridge Too Far? Towards Medical Therapy for Clinically Nonfunctioning Pituitary Tumors

By afschroeder • June 26, 2025

Mogar N, Zhang D, Heaney AP. A Bridge Too Far? Towards Medical Therapy for Clinically Nonfunctioning Pituitary Tumors. Int J Mol Sci. 2025 Jun 19;26(12):5898. doi: 10.3390/ijms26125898. PMID: 40565361.

Tags: clinically nonfunctioning pituitary tumors, dopamine receptor agonist, Endocrinology, medical treatment, molecular pathogenesis, Publications, Radiation, somatostatin receptor ligand, Surgery

Metabolic Messengers: oestradiol

Hevener AL, Correa SM. Metabolic Messengers: oestradiol. Nat Metab. 2025 Jun;7(6):1114-1122. doi: 10.1038/s42255-025-01317-7. Epub 2025 Jun 24. PMID: 40562968.

Efficacy and immune-related adverse events of pembrolizumab with bone-modifying agents in female patients with breast cancer

LeVee A, Peluso E, Lechner MG, Ruel N, Mortimer J, Kang I, Tsai K. Efficacy and immune-related adverse events of pembrolizumab with bone-modifying agents in[...]

Care Coordination for High-Need, High-Cost Commercially Insured Patients: A Randomized Clinical Trial

Duru OK, Harwood J, Moin T, Takada S, Tseng CH, Saju R, Lee E, Fatehpuria A, Mangione CM. Care Coordination for High-Need, High-Cost Commercially Insured[...]